Podcasts about multidisciplinary

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights - Multidisciplinary, WCLC26 deadlines and information about Seoul. Guests: Myung-Ju Ahn, MD, PhD Distinguished Professor Section of Hematology-Oncology, Department of Medicine Hanyang University Medical Center, Hanyang University School of Medicine Seoul, Republic of Korea Vincent Wentao Fang, MD Professor, Department of Thoracic Surgery Shanghai East Hospital Tongji University Medical School Jiraporn Setakornnukul, MD, PhD Radiation Oncologist, Associate Professor Division of Radiation Oncology Department of Radiology Faculty of Medicine, Siriraj Hospital Mahidol University Bangkok, Thailand Yasushi Yatabe, MD, PhD Chief, Department of Diagnostic Pathology, National Cancer Center Hospital Chief, Division of Molecular Pathology, National Cancer Center Research Institute National Cancer Center Japan

In this episode of Better Edge, Transplant Hepatologist Laura Lulik, MD moderates a panel discussion about the Northwestern Medicine Liver Transplant Tumor Clinic. The conversation covers advances in imaging, systemic therapies and innovative procedures, as well as the clinic's multidisciplinary approach.The panel includes: • Daniel Borja, MD, transplant surgeon• Aparna Kalyan, MD, medical oncologist • Robert Lewandowski, MD, interventional radiologist• Amira Borhani, MD, abdominal radiologist

The following article of the Health industry is: 'The Critical Role of Multidisciplinary Care in Rare Diseases' by David López García, General Director Mexico, Recordati Rare Diseases. 

Multidisciplinary astrophysicist, inventor, award-winning author, and journalist Hakeem Oluseyi joins Tavis in studio to discuss his newest book, “Why Do We Exist? The Nine Realms Of The Universe That Make You Possible,” and more.Become a supporter of this podcast: https://www.spreaker.com/podcast/tavis-smiley--6286410/support.

CardioNerds (Dr. Billy-Joe Mullinax, Dr. Dinu Balanescu, and Dr. Jane Ehret) discuss risk stratification in acute pulmonary embolism with Dr. Stavros Konstantinides, Chair of the 2019 ESC Pulmonary Embolism Guidelines. Using a real-world case, this episode explores how modern PE care has moved beyond “massive” and “submassive” labels toward a dynamic, physiology-based approach. The discussion highlights the limitations of static risk scores, the importance of right ventricular dysfunction and biomarkers, and why normotension does not imply stability. Special emphasis is placed on intermediate-high risk PE, early identification of impending hemodynamic collapse, and the role of lactate, serial reassessment, and PERT teams in guiding escalation of care. Audio editing by CardioNerds intern, Joshua Khorsandi.The 2026 American multi-society PE guidelines were published after this episode was recorded. Dr. Dinu Balanescu and Dr. Billy-Joe Mullinax are Co-chairs for the CardioNerds PE Series, developed in collaboration with the PERT Consortium.   Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Pulmonary Embolism PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Stable blood pressure does not mean low risk in PEHypotension is a late finding. Patients may have severe RV failure, hypoxia, and tissue hypoperfusion while remaining normotensive — a key concept behind “normotensive shock.” Risk stratification in PE must be dynamic, not staticLegacy scores like PESI and Bova provide a snapshot and predict 30-day mortality, but they do not capture short-term trajectory or impending hemodynamic collapse. Intermediate-high risk PE is a dangerous and heterogeneous groupPatients with RV dysfunction, positive biomarkers, tachycardia, hypoxemia, and elevated lactate may have in-hospital mortality approaching 15%, rivaling STEMI. Lactate is a critical but underutilized marker in PEElevated lactate reflects tissue hypoxia and early circulatory failure and may identify patients at risk for collapse before blood pressure declines. PERT enables physiology-driven, patient-centered PE carePERT teams operationalize continuous reassessment, integrate imaging, labs, and clinical trajectory, and allow timely escalation — shifting PE management from rigid categories to real-time decision-making. Notes Drafted by Dr. Jane Ehret. 1. What is the contemporary framework for risk stratification in acute pulmonary embolism? Modern PE risk stratification prioritizes hemodynamics and right ventricular (RV) function rather than clot burden. The 2019 ESC Guidelines classify PE into high risk, intermediate risk (low vs high), and low risk, based on: Hemodynamic status, RV dysfunction on imaging, and Cardiac biomarkers. This framework emphasizes early mortality risk but requires clinical context to guide escalation decisions. 2. Why is normotension insufficient to define “stability” in PE? Blood pressure is a late marker of circulatory failure in PE. Patients can maintain normal BP through Tachycardia, Increased sympathetic tone, and RV compensation. Many patients with preserved BP may already have shock physiology, including hypoxemia, elevated lactate, and RV failure — sometimes referred to as “normotensive shock.” 3. How should intermediate-risk PE be conceptualized clinically? Intermediate-risk PE is heterogeneous, ranging from patients who do well on anticoagulation to those who deteriorate rapidly. Intermediate-high risk PE is defined by RV dysfunction on imaging and positive cardiac biomarkers. Clinical features such as tachycardia, increasing oxygen requirement, and elevated lactate identify patients at highest risk within this group. 4. What are the strengths and limitations of commonly used PE risk scores? Legacy scores are useful for initial risk categorization but are static and limited in predicting short-term deterioration. Most scores were developed to predict mortality or complications at fixed time points rather than dynamic clinical trajectory. 5. What are the commonly used risk scores and clinical tools in PE, and what is each designed to predict? ESC Risk Stratification Algorithm: Identifies high-risk PE by hemodynamics. Uses PESI or sPESI in normotensive patients to distinguish low-risk from non–low-risk PE. Uses RV dysfunction and biomarkers to differentiate intermediate-low from intermediate-high risk. Forms the basis of many institutional PE pathways. PESI and sPESI: Validated to predict 30-day mortality. Widely used to identify low-risk patients appropriate for outpatient management. Heavily influenced by age and comorbidities. Bova Score: Predicts 30-day PE-related complications in normotensive patients. Composite PE Shock Score (CPES): Predicts normotensive shock in hemodynamically stable PE patients. Pulmonary Embolism Progression (PEP) Score: Predicts progression from intermediate-risk to high-risk PE within 72 hours of diagnosis. PE Short-term Clinical Outcomes Risk Estimation (PE-SCORE): Predicts clinical deterioration or death within 5 days of PE diagnosis. Hestia Criteria: Identifies low-risk PE patients safe for outpatient treatment. Wells' Criteria and Revised Geneva Score: Determine pretest probability for diagnostic triage. PERC Score: Rules out PE in very low-risk patients. 6. What is the role of biomarkers in PE risk stratification? Troponin and natriuretic peptides reflect RV myocardial injury and strain. Current guidelines treat biomarkers as binary (positive vs negative), despite risk being continuous. Biomarkers are most helpful for: Initial risk classification. They are less useful for: Short-interval monitoring and Detecting rapid clinical deterioration. 7. Why is lactate an important physiologic marker in PE? Lactate reflects global tissue hypoxia and impaired perfusion. Elevated lactate may identify patients with: Early circulatory failure and Increased risk of imminent hemodynamic collapse. Lactate is not currently included in ESC risk algorithms but may add important prognostic information in intermediate-risk patients. 8. How does trajectory influence decision-making in PE management? Risk stratification should be viewed as a dynamic process, not a one-time label. Worsening clinical trajectory may include: Rising heart rate, Increasing oxygen needs, Rising lactate, and Progressive RV dysfunction. Serial reassessment is essential for timely escalation of care. 9. What role do Pulmonary Embolism Response Teams (PERT) play in risk stratification? PERT facilitates: Multidisciplinary decision-making and Integration of imaging, biomarkers, and clinical physiology. PERT is most valuable for: Intermediate-risk and high-risk PE and Patients with complex comorbidities or uncertain trajectory. PERT enables a shift from category-based to physiology-driven PE care. References 1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3):1901647. Published 2019 Oct 9. doi:10.1183/13993003.01647-2019 2. Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. J Clin Med. 2022;11(9):2533. Published 2022 Apr 30. doi:10.3390/jcm11092533 3. Choi WH, Kwon SU, Jwa YJ, et al. The pulmonary embolism severity index in predicting the prognosis of patients with pulmonary embolism. Korean J Intern Med. 2009;24(2):123-127. doi:10.3904/kjim.2009.24.2.123 4. Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383-1389. doi:10.1001/archinternmed.2010.199 5. Chen X, Shao X, Zhang Y, et al. Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis. Thromb Res. 2020;193:99-106. doi:10.1016/j.thromres.2020.05.047 6. Zhang RS, Yuriditsky E, Zhang P, et al. Composite Pulmonary Embolism Shock Score and Risk of Adverse Outcomes in Patients With Pulmonary Embolism. Circ Cardiovasc Interv. 2024;17(8):e014088. doi:10.1161/CIRCINTERVENTIONS.124.014088 7. Zhang RS, Alam U, Sharp ASP, et al. Validating the Composite Pulmonary Embolism Shock Score for Predicting Normotensive Shock in Intermediate-Risk Pulmonary Embolism. Circ Cardiovasc Interv. 2024;17(2):e013399. doi:10.1161/CIRCINTERVENTIONS.123.013399 8. Ehret J, Wakefield D, Badlam J, Antkowiak M, Erdreich B. Development of the Pulmonary Embolism Progression (PEP) score for predicting short-term clinical deterioration in intermediate-risk pulmonary embolism: a single-center retrospective study. J Thromb Thrombolysis. 2025;58(2):243-253. doi:10.1007/s11239-024-03051-5 9. Weekes AJ, Raper JD, Lupez K, et al. Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE). PLoS One. 2021;16(11):e0260036. Published 2021 Nov 18. doi:10.1371/journal.pone.0260036 10. Zondag W, Hiddinga BI, Crobach MJ, et al. Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism. Eur Respir J. 2013;41(3):588-592. doi:10.1183/09031936.00030412 11. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001;135(2):98-107. doi:10.7326/0003-4819-135-2-200107170-00010 12. Wolf SJ, McCubbin TR, Feldhaus KM, Faragher JP, Adcock DM. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004;44(5):503-510. doi:10.1016/j.annemergmed.2004.04.002 13. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144(3):165-171. doi:10.7326/0003-4819-144-3-200602070-00004 14. Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004;2(8):1247-1255. doi:10.1111/j.1538-7836.2004.00790.x 15. Kline JA, Courtney DM, Kabrhel C, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008;6(5):772-780. doi:10.1111/j.1538-7836.2008.02944.x

In this episode of Precision and Progress: Radiotherapy in Oncology, hosts Hirsch Matani, MD, and Elizabeth Zhang-Velten, MD, PhD, welcomed Binh T. Ngo, MD, to discuss the evolving role of radiation, systemic therapy, and multidisciplinary care for patients with melanoma and other skin cancers.Dr Matani is a clinical assistant professor of radiation oncology at the Keck School of Medicine of the University of Southern California (USC) and a radiation oncologist at the USC Norris Comprehensive Cancer Center. Dr Zhang-Velten is a radiation oncologist and a clinical assistant professor with Keck Medicine of USC. Dr Ngo is an assistant professor of dermatology at Keck Medicine of USC.In their discussion, Drs Matani, Zhang-Velten, and Ngo broke down how surgical approaches, radiation, and systemic therapy all play roles in the treatment of patients with skin cancer. Dr Ngo highlighted key prevention strategies that patients should be advised on, along with recommended follow-ups for patients who are at higher risk or those who underwent prior solid organ or hematologic transplants.The trio also discussed how the use of radiation for patients with skin cancer varies from techniques used for patients with tumors located within deeper organs, and they also highlighted how radiotherapy approaches could be applied for patients with tumors that would be difficult to surgically resect.

Niyi Adeogun is a multidisciplinary artist, creative director, and founder of CXRE Labs, a creative studio exploring the intersection of art, design, and technology. His work spans visual art, brand identity, immersive experiences, and experimental design, often using symbolism and storytelling to create pieces that feel both personal and thought-provoking.Originally from Lagos, Nigeria, and now based in Canada, Niyi's practice is rooted in curiosity, emotion, and innovation. He is passionate about creating work that not only looks compelling but also invites deeper reflection on identity, connection, faith, and the human experience.Through his studio and personal practice, Niyi continues to build projects that blur the lines between disciplines, bringing together art, design, and emerging technology in ways that feel meaningful, accessible, and alive.Check him out @niyiadeogun

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

View the full article at: https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon Tumor boards play a pivotal role in oncology care. For clinicians, they represent the ideal environment: multiple specialists, shared context, and time to debate the gray areas that guidelines can't fully capture. However, during a busy afternoon in the clinic, the plans developed in tumor boards often prove less straightforward to implement. In this episode of Oncology Unfiltered, Melissa Cutrona, MS, and Matthew Hadfield, DO, OncData Editor in Chief, unpack why tumor boards are so valuable, where they fall short, and how to bridge the gap between a coordinated plan and the reality of care delivery on a busy clinic day.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

In today's episode, we spoke with Anthony Chi, MD, a staff pathologist; Monica Peravali, MD, a medical oncologist; and Archana Jadhav, MD, a medical oncologist, all faculty at the Mid-Atlantic Permanente Medical Group in Maryland. In our exclusive interview, Drs Chi, Peravali, and Jadhav discussed the practical advantages and clinical implications of implementing in-house next-generation sequencing (NGS) testing for patients with non–small cell lung cancer (NSCLC). The conversation focused on how internal molecular testing platforms can improve turnaround times, optimize tissue stewardship, reduce costs, and enhance quality control across the diagnostic and treatment continuums.Chi explained that performing NGS internally eliminates delays associated with specimen transportation and external laboratory accessioning, significantly shortening turnaround times. He also highlighted Kaiser Permanente's decision to implement a molecular platform distinct from those commonly used by outside vendors, allowing for reduced tissue input requirements and faster processing times. According to Chi, internal testing also gives pathology teams greater oversight of specimen use, enabling more strategic tissue conservation for future immunohistochemical (IHC) staining, repeat molecular analyses, or additional biomarker testing.The panel emphasized the importance of close coordination between pathology and oncology teams in maximizing tissue adequacy, particularly in small biopsies and cytology specimens. Chi described educational initiatives implemented within pathology departments to encourage judicious use of IHC stains and preserve tissue for downstream molecular testing. He also outlined specimen-handling workflows in which tissue is divided into separate cassettes to prioritize molecular analysis and still supporting diagnostic evaluation.Jadhav discussed the oncologist's role in ensuring adequate tissue acquisition, emphasizing proactive communication with pathologists and interventional radiologists. She noted that when clinicians anticipate limited tissue yield, such as in pleural fluid cytology specimens, they often promptly arrange additional biopsies to avoid delays in treatment initiation and ensure comprehensive genomic profiling can be completed efficiently.The discussion also addressed optimal timing for comprehensive genomic profiling in NSCLC. Peravali explained that Kaiser Permanente routinely performs NGS across all disease stages, including early-stage disease, due to increasing use of neoadjuvant chemoimmunotherapy approaches and the need to identify actionable biomarkers that may influence treatment selection. Although in-house testing serves as the primary platform, she noted that send-out testing remains important in select situations, including cancers of unknown primary origin, clinical trial enrollment, and discordant or clinically suspicious cases requiring additional confirmation.As molecular reports become increasingly complex, the panel highlighted the importance of interpreting co-mutations, variants of unknown significance, and emerging biomarkers within a broader clinical context. Peravali explained that although variants without current therapeutic relevance may not immediately affect treatment decisions, repeat biopsies and serial NGS at disease progression can reveal newly actionable alterations as therapeutic options evolve.Chi further emphasized the growing importance of newly approved biomarkers, including HER2 and c-MET alterations, in NSCLC. He described how pathology teams actively monitor FDA approvals and National Comprehensive Cancer Network (NCCN) guideline updates to identify new therapeutic opportunities for previously profiled patients. In some cases, archived tumor specimens are revisited for additional IHC testing when emerging therapies become clinically relevant.The conversation also highlighted the value of multidisciplinary collaboration and tumor board discussions in complex diagnostic scenarios. The speakers described how integrated molecular analysis can help distinguish separate primary lung tumors from metastatic disease, resolve diagnostically challenging cases involving uncommon metastatic presentations, and support more confident staging and treatment decisions.Finally, the panel underscored that successful implementation of precision oncology workflows depends on seamless collaboration among pulmonologists, pathologists, oncologists, interventional radiologists, and molecular laboratories. Early test ordering, centralized communication systems, and multidisciplinary case review were identified as key components of efficient, patient-centered care that can accelerate diagnosis and improve treatment planning for patients with lung cancer.

In this episode of Head and Neck Innovations, Edward Doyle, MD, and Varun Kshettry, MD, join host Paul Bryson, MD, to discuss the diagnosis and management of cerebrospinal fluid (CSF) leaks and encephaloceles. They explore common presentations, advances in imaging and diagnostic testing, and collaborative surgical approaches for skull base repair. The conversation also highlights the growing recognition of idiopathic intracranial hypertension as an underlying cause of spontaneous CSF leaks, as well as emerging treatment strategies including venous sinus stenting, weight management, and GLP-1 receptor agonists.

Multidisciplinary musician and video game composer Floor Baba was the focus of "Hot Takes" episode 100! After a prolonged period of not having Quiz on the show as co-host, we finally got him back and with a terrific pull too! Known for their work on the soundtracks for Pac Man: Snack Break and Egg Squeeze, their affiliation with the Pluswav Cooperative, and their wonky, futuristic take on vapor-adjacent experimental electronic music; two hours was seemingly only enough to scratch the surface of Jesse's experience, as we heard their history and fielded questions from the live chat as well. We conversed about 90's and 2000's Christian music and what it's like to compose soundtracks for video games. A lot of talk about how much cratedigging transpires daily and how Floor Baba likes to listen to music took place. Other topics that came up in conversation include the stories behind some of Jesse's album artwork, the psychological horror of playing Egg Squeeze,  their favorite composers, starting a label, and their favorite N64 OST's. The memorable moments we got to spend with Floor Baba that night cannot be quantified, so what are you waiting for? Hit play!   "Hot Takes" is a safe space for all opinions! Join the conversation at https://linktr.ee/hottakesvapor

Multidisciplinary artist Maxi Glamour has shared their storytelling prowess through songwriting, drag and queer-friendly events by way of their Faeded series. Recently, they have completed “Faeded: The Opera” which premieres June 5 at the Contemporary Art Museum in partnership with the Pulitzer Arts Foundation. Glamour gives us a peek into their motivations to write their first opera, the evolution of Faeded over the years and their take on how “queerness” transcends sexual orientation.

In this episode, Ronjon Paul, MD, Orthopedic Spine Surgeon, Endeavor Health Medical Group, discusses developing multidisciplinary spine programs, leading within a large health system, and how AI is transforming patient care, clinical decision making, and physician workflows.

In this episode, CardioNerds Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Yong Hao Yeo are joined by electrophysiology expert Dr. Bradley Knight to discuss atrial fibrillation (AF) management in challenging clinical scenarios. We explore arrhythmias in patients with pre-excitation syndromes, particularly Wolff-Parkinson-White (WPW) syndrome, and strategies for rhythm control. We also discuss AF management in pregnancy, adult congenital heart disease, and patients with tachycardia-bradycardia (tach-brady) syndrome. This episode provides essential insights into nuanced decision-making for the care of patients with complex arrhythmia profiles. Audio editing by CardioNerds academy intern, Grace Qiu. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! PEARLS AF in WPW is a true emergency—AV nodal blocking agents can be deadly. In patients with WPW syndrome, AF can rapidly conduct through the accessory pathway, risking ventricular fibrillation and sudden death. Avoid AV nodal blockers like beta-blockers and calcium channel blockers. Catheter ablation is the first-line rhythm control strategy in WPW. Catheter ablation carries a Class I recommendation and offers >90% success. If antiarrhythmic drugs are needed, sodium channel blockers like flecainide or propafenone are preferred in patients without structural heart disease. In pregnancy, protecting the mother is protecting the fetus. An unstable mother means an unstable fetus. Rate control is the first step in AF with rapid ventricular responses and electrical cardioversion is safe when needed. Multidisciplinary care is essential. AF in congenital heart disease is often outside the pulmonary veins. Surgical scars and chamber remodeling in ACHD patients often lead to AF from non-pulmonary vein foci. Electrogram-based mapping and targeted ablation strategies are essential to increase success rate of durable rhythm control. Tachy-brady syndrome may require pacing to unlock therapy. AF may cause atrial myopathy and sinus node dysfunction. These patients often require permanent pacing to allow safe use of rate-controlling medications like beta-blockers and to prevent syncope or chronotropic incompetence. Notes: Notes drafted by Dr. Yong Hao Yeo Why is atrial tachycardia in patients with WPW syndrome dangerous? Patients with WPW commonly present with supraventricular tachycardia (SVT) due to atrioventricular reentrant circuits, either orthodromic or antidromic. This SVT can degenerate into AF. In the absence of AV nodal as the governor between the atrium and ventricles, the accessory pathway may conduct impulses rapidly and frequently. This can lead to dangerously high ventricular rates, predisposing patients to ventricular fibrillation and sudden cardiac arrest. What are some strategies for rhythm control in patients with WPW and atrial tachycardia? Catheter ablation is the first-line therapy (Class I recommendation), with a success rate of over 90%. Ablation reduces the risk of sudden cardiac arrest, though some patients may remain prone to AF. If ablation is not feasible/ contraindicated, sodium channel blockers such as flecainide and propafenone are good options in patients without ischemia or structural heart disease (Class IIa recommendation). Amiodarone should be avoided because it has a long half-life, can accumulate in the system, and may delay definitive treatment with catheter ablation. AV nodal blocking agents like beta blockers and calcium channel blockers should be avoided, as they are less effective at controlling ventricular rate in WPW and can increase conduction over the accessory pathway. These agents can also exacerbate the risk of rapid ventricular rates during AF and worsen left ventricular function. What are some special considerations in managing AF in pregnant patients? The primary goal in managing cardiovascular disease during pregnancy is to protect the mother, as fetal outcomes depend on maternal well-being. Therefore, while caution is necessary, we should avoid undertreating pregnant patients with AF. In cases of AF with rapid ventricular response (RVR), rate control is usually the first-line strategy, with beta blockers preferred over digoxin or non-dihydropyridine calcium channel blockers. It is then reasonable to initially observe for spontaneous conversion in stable patients. Antiarrhythmic drugs (AADs) are generally avoided during the first trimester, but clinical judgment on a case-by-case basis is essential. Evidence for the safety of AADs in pregnancy is limited, often derived from their use in other conditions such as fetal SVT. Flecainide and sotalol are reasonable options for rhythm control (Class IIa recommendation). Electrical cardioversion is considered safe in pregnancy and should be utilized when indicated (Do not forget!). There is no pregnancy-specific thromboembolic risk stratification tool. CHA₂DS₂-VASc scoring and the presence of risk factors like mitral stenosis can help guide anticoagulation decisions, though the magnitude of thromboembolic risk during pregnancy remains unclear. Rate control agents are typically continued during delivery due to the increased physiologic stress of labor and delivery. Multidisciplinary care is crucial and should involve obstetrics, maternal-fetal medicine, cardiology, and electrophysiology specialists. What are some key considerations for AF management in patients with adult congenital heart disease (ACHD)? Patients with repaired congenital heart disease are at increased risk for arrhythmias due to two main factors: surgical scars that create arrhythmogenic foci and mechanical remodeling of the atria or ventricles resulting from the underlying disease. In these patients with structural heart disease, sodium channel blockers may not be ideal antiarrhythmic options. When selecting an antiarrhythmic drug, clinicians must consider the nature of structural or surgical impairments, such as right bundle branch block or prolonged QT interval. It is also essential to assess renal and hepatic function (often impaired in patients with ACHD) to ensure appropriate metabolism and clearance of antiarrhythmic medications. Electrogram-based ablation strategies (those leveraging artificial intelligence are developing!) may help identify effective ablation targets, which are often outside the pulmonary veins in patients with ACHD. These individualized approaches can improve ablation success rates in this complex patient population. What makes tachycardia-bradycardia (tach-brady) syndrome a unique challenge in arrhythmia management? Patients who present with both AF and bradycardia, especially with syncope, require a thoughtful diagnostic approach to identify the underlying rhythm disturbance. Extended cardiac monitoring, including event monitors or implantable loop recorders, can help capture intermittent arrhythmias and correlate them with symptoms. AF may lead to atrial myopathy, and since the sinus node resides within the atrium, this can result in sinus node dysfunction—a hallmark of tachy-brady syndrome. Following spontaneous conversion from AF to sinus rhythm, sinus node dysfunction may persist, leading to prolonged pauses or chronotropic incompetence. Management becomes more complex when beta-blockers are needed for AF with RVR, as they can exacerbate bradycardia. Permanent pacemaker implantation is often the next step to consider. Permanent pacemaker implantation is often considered to facilitate safe rate control in these cases. In younger patients, aggressive AF burden reduction may prevent atrial remodeling and the development of true atrial myopathy, potentially avoiding pacemaker implantation. References Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;149(1). doi:https://doi.org/10.1161/CIR.0000000000001193 ‌ Van IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2024;45(36). doi:https://doi.org/10.1093/eurheartj/ehae176 ‌ Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm. Published online May 1, 2023. doi:https://doi.org/10.1016/j.hrthm.2023.05.017 ‌ Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary. Journal of the American College of Cardiology. 2019;73(12):1494-1563. doi:https://doi.org/10.1016/j.jacc.2018.08.1028 ‌

They explain how occupational therapists, physical therapists, mental health professionals, pharmacists, and others can help you manage fatigue, pain, anxiety, daily routines, and life after diagnosis, while also sharing practical tips for advocating for referrals and support.  Episode at a glance: Why autoimmune arthritis care involves more than a rheumatologist and medications The surprising evidence behind occupational therapy (OT), physical therapy, and mental health support How OT can help with fatigue, pacing, daily routines, parenting, work, and mental health, not just hand pain Why anxiety, grief, and depression are common after diagnosis, and why getting support early matters Real-life strategies for managing fatigue and adapting daily tasks without “giving up” The hidden barriers that prevent patients from accessing multidisciplinary care Tips for advocating for referrals and building a supportive care team Cheryl and Eileen's personal experiences navigating rheumatoid arthritis, fatigue, anxiety, and self-management   Medical disclaimer:  All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE,  an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected.  See all the details  and join the program or waitlist now! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Ronjon Paul, MD, Orthopedic Spine Surgeon, Endeavor Health Medical Group, discusses developing multidisciplinary spine programs, leading within a large health system, and how AI is transforming patient care, clinical decision making, and physician workflows.

In this episode, Ronjon Paul, MD, Orthopedic Spine Surgeon, Endeavor Health Medical Group, discusses developing multidisciplinary spine programs, leading within a large health system, and how AI is transforming patient care, clinical decision making, and physician workflows.

Please visit answersincme.com/860/101385133-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Peter A. Fasching, MD; Michael Gnant, MD, FACS; and Cristina Saura Manich, MD, PhD. In this activity, experts in breast cancer discuss new evidence in neoadjuvant and adjuvant care of early disease. Upon completion of this activity, participants should be better able to: Describe multidisciplinary viewpoints on the role that HER2-directed ADCs may play in the (neo)adjuvant setting for HER2-positive early-stage breast cancer; Evaluate evidence for the (neo)adjuvant use of HER2-directed ADCs in the multidisciplinary management of HER2-positive early-stage breast cancer; and Formulate evidence-based multidisciplinary strategies to optimally incorporate (neo)adjuvant HER2-directed ADCs into the treatment paradigm for HER2-positive early-stage breast cancer.

Professor Tara Renton OBE brings four generations of dental history — and a career built on curiosity rather than ambition — to her conversation with Payman. From navigating undiagnosed dyslexia and a father who begged her not to follow him into dentistry, to becoming the first female chair of oral surgery at King's College London, her story is one of serendipity, resilience, and an almost obsessive interest in the patient behind the pain. She shares remarkable insights into orofacial pain — nerve injuries, psychosocial histories, patients whose chronic pain only begins to shift when someone finally takes the time to ask the right question — and makes a compelling case for multidisciplinary thinking in a profession she feels has been far too siloed for far too long. Sharp reflections on surgical safety, local anaesthetic technique, and the state of dental education sit alongside something warmer: a life philosophy that's disarmingly simple. Stay curious.In This Episode00:02:50 - Four generations of dentists00:06:05 - Child dental health crisis00:07:20 - New grandmother00:10:00 - Choosing dentistry00:17:05 - Serendipity over ambition00:37:15 - The juggle: three kids and a PhD00:41:00 - Bullying and misogyny in surgery00:44:45 - King's: first chair in oral surgery00:47:35 - Multidisciplinary pain clinic00:49:25 - The Iranian patient00:56:00 - Trust underpins consent01:00:00 - Classifying orofacial pain01:07:05 - When grief resolves chronic pain01:12:15 - Blackbox thinking01:17:00 - Local anaesthetic tips01:22:00 - Wrong site surgery01:25:30 - Dental student selection01:27:15 - Redesigning the dental course01:47:50 - Bruxism: rethinking the evidence01:50:15 - Fantasy dinner party01:53:45 - Last days and legacyAbout Professor Tara Renton OBEProfessor Tara Renton OBE is Emeritus Professor of Oral Surgery at King's College London Dental Institute, where she became the first female chair of oral surgery — and one of the world's leading authorities on orofacial pain and nerve injury. Over a career spanning more than 40 years, she has authored over 250 research papers, completed a PhD centred on morbidity following third molar surgery, established a pioneering multidisciplinary pain clinic at King's, and carried out extensive medico-legal work in surgical safety. She is the co-founder of the patient resource orofacialpain.org.uk.

In this episode, host Shikha Jain, MD, speaks with Jessica MacIntyre, DNP, about her role and goals as president of the Oncology Nursing Society, multidisciplinary focuses within cancer care and more. ·       Welcome to another exciting episode of Oncology Overdrive 1:22 ·       About Jessica MacIntyre, DNP, MBA, APRN, AOCNP, FAANP 1:34 ·       The interview 2:50 ·       Tell me about how you got to where you are today […] What was your journey to becoming a nurse practitioner, and into the leadership role you hold today? 3:15 ·       What is Oncology Nursing Society (ONS)? What does it do, and how did you become president?  5:17 ·       What are your goals as president of ONS? 9:08 ·       Jain and MacIntyre on the importance of multidisciplinary approaches to cancer care. 12:28 ·       What excites you about the role of nurses and nurse practitioners, and the future of the oncology team as a whole? 14:34 ·       Where do you see the future of patient navigation going? […] Where do you see AI playing a role in all of this? 17:42 ·       What do you say to people who are scared of AI becoming all-encompassing? 20:41 ·       Jain and MacIntyre on embracing and improving the use of AI in cancer care. 22:14 ·       What do you recommend to nurses as they embark on their careers? […] How can we make sure nurses are working to the top of their license while supporting the cancer care team? 24:09 ·       Jain and MacIntyre on the increasing importance of advocacy in health care. 26:55 ·       If someone could only listen to the last minute of this episode, what would you want listeners to take away? 28:31 ·       How to contact MacIntyre 30:00 ·       Thanks for listening 30:56 Jessica MacIntyre, DNP, MBA, APRN, AOCNP, FAANP, is president of the Oncology Nursing Society and executive director of clinical operations at Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. MacIntyre can be reached on LinkedIn, or via email jmacintyre@med.miami.edu. Jain reports no relevant financial disclosures. MacIntyre reports compensation from Johnson & Johnson for participation on a nursing panel.

In this powerful episode, Dr. Lynn Hellerstein speaks with Glenn Sturm, bestselling author, astrophotographer, and 18 years on chemo and counting. Guided by values like “Sturms never quit,” Glenn shares how he pursues passion, spreads positivity, and refuses to let cancer define his life. He highlights the impact of a multidisciplinary cancer care team where specialists collaborate and patients are part of the decision-making. This approach can significantly reduce mortality and improve quality of life compared to solo care. From managing cancer fatigue to using simple remedies like ginger for nausea, Glenn shares practical ways to navigate treatment. Originally given 2.5 years to live, he's now looking at 30—crediting team-based care and self-advocacy. Despite its benefits, multidisciplinary care faces barriers like insurance and provider resistance particularly in the United States. While it's typical to find palliative care team and tumor boards in hospitals, it is more challenging to find a true multidisciplinary cancer care team. Glenn's mission is to raise awareness and encourage patients to seek better, more collaborative care through his books Warrior Hate War, Cancer Set Me Free and his upcoming work More Than Hope. Dr. Lynn Hellerstein, Developmental Optometrist, co-owner of Hellerstein & Brenner Vision Center, P.C., award-winning author and international speaker, holds powerful and inspiring conversations with her guests in the areas of health, wellness, education, sports and psychology. They share their inspirational stories of healing and transformation through their vision expansion. Vision Beyond Sight Podcast will help you see with clarity, gain courage and confidence. Welcome to Vision Beyond Sight! Also available on Apple Podcasts, iTunes, Google Podcasts, Spotify, iHeart Radio, Audible and Stitcher.

Join AONN+ Executive Director Candice Roth, MSN, RN, CENP,  and experts from the University of California, San Diego (UCSD) as they explore the complexities of managing hepatocellular carcinoma (HCC) in this latest episode of the Heart and Soul of Oncology Navigation, facilitated by the Society of Interventional Oncology.Discover the unique features that set HCC apart from other solid tumors, including its nuanced diagnosis, and learn how UCSD's multidisciplinary team approach is empowering patients and transforming HCC care for a new era. If you're a healthcare provider involved in liver cancer care or want to understand how cutting-edge collaboration enhances survival and quality of life for patients with HCC, this episode is your essential guide. Thank you to our guests from UCSD for joining us for this insightful conversation:Zach Berman, MD, Interventional RadiologistAdam Burgoyne, MD, PhD, Medical OncologistYuko Kono, MD, PhD, FAIUM, FAASLD, HepatologistSam Myers, RN, OCNResources & LinksSociety of Interventional OncologyContact Heart & Soul of Oncology Navigation- Follow AONN+ on LinkedIn, Instagram, Facebook, and YouTube- Contact us at communications@aonn.orgThanks for listening!

In this episode, Edward J. Dohring, M.D., of the Spine Institute of Arizona, discusses the value of multidisciplinary collaboration, emerging innovations in spine care, and the evolving role of AI and minimally invasive approaches. He also shares insights on improving patient outcomes, balancing cost and quality, and shaping the next generation of spine leaders.

Send us Fan MailPhoto of Zoë Buckman by Abbey Druckershow notes:1:10 background as a multi-media visual artist7:00 Buckman's dialogue with agency9:25 her use of embroidery10:40 filmmaking11:00 Show Me Your Bruises, Then14:25 exhibition at the Perez Museum 18:50 power of art22:00 Artist Tracey Ehmann  23:45 exploration of personal issues in her work 26:15 her work on Jewish personhood 34:30 erasure and gaslighting of Jewish artists37:00 show at Mindy Solomon Gallery 41:00 Jewish people's complicated relationship with the home42:45 her definition of justice / injustice 45:40 how her work addresses her view of justice / injustice49:30 use of vintage textiles51:45 coffee table book52:45 2027 NY show53:30 collaboration with Actress Cush Jumbo54:50 the legacy Buckman hopes to make with her work56:15 multiple truths she addresses in her workPlease share your comments and/or questions at stephanie@warfareofartandlaw.comMusic by Toulme.To hear more episodes, please visit Warfare of Art and Law podcast's website.To leave questions or comments about this or other episodes of the podcast and/or for information about joining the 2ND Saturday discussion on art, culture and justice, please message me at stephanie@warfareofartandlaw.com. Thanks so much for listening!This podcast and its content may not be used for training or developing AI systems without permission.© Stephanie Drawdy [2026]

Knitters and crocheters know Angela Tong as a designer with hooks and needles, while weavers recognize her work in rigid-heddle and pin looms. Visitors to galleries and artisan markets know her as a potter. Angela thinks of herself simply as a maker, always drawn to creating beauty with her hands. Her first professional job set the tone: after earning a degree from the Fashion Institute of Technology, she produced fine platinum jewelry for Tiffany & Co. But beginning in her teens, she keenly felt the urge to learn to knit. A colleague at that first job taught her the knit stitch—just the knit stitch—and opened the world of fiber arts for her. Discovering a talent for clarifying instructions while test knitting other designers' work, she began submitting designs for publication. Although she had not initially pictured herself as a teacher, that skill of clear explanation led her to teaching, and she eventually became a certified knitting instructor. Angela discovered another fiber-arts love in PieceWork March/April 2010, which featured pin looms on the cover. She tracked down a handmade pin loom from a small maker, wove a doll blanket, and never looked back. Her pin-loom and rigid-heddle designs regularly appear in Little Looms, and she is a popular instructor at Weave Together events. In each of her crafts, Angela's style is symmetrical and refined, with an emphasis on finishing that she describes as a through line in everything she makes, from pottery to pin-loom blankets. Whatever the medium, Angela brings the same exacting eye and genuine delight in craft — whether she's warping a loom, trimming a pot, or teaching a roomful of students to hem stitch. Links PieceWork March/April 2010 featured a pin-loom blanket on the cover. Angela's pin loom videos Creative Pin-Loom Designs and Weave Patterns on the Pin Loom are available from Long Thread Media. Angela was featured in the pilot episode of the proposed Swatch series. This episode is brought to you by: Treenway Silks is where weavers, spinners, knitters and stitchers find the silk they love. Select from the largest variety of silk spinning fibers, silk yarn, and silk threads & ribbons at TreenwaySilks.com. You'll discover a rainbow of colors, thoughtfully hand-dyed in Colorado. Love natural? Treenway's array of wild silks provide choices beyond white. If you love silk, you'll love Treenway Silks, where superior quality and customer service are guaranteed.

For patient referrals: call 602-521-5700What if one of the most common yet misunderstood gynecologic conditions could be diagnosed earlier—without surgery? In this episode of Beyond the Rounds, we explore endometriosis, a condition affecting nearly 190 million people worldwide that still takes an average of 7-10 years to diagnose. Dr. Nolan Fisher sits down with gynecologic surgeon and endometriosis specialist Dr. Rosanne Kho to discuss how advances in imaging, multidisciplinary care and minimally invasive surgery are reshaping the diagnostic and treatment paradigm.Endometriosis is often dismissed or normalized, leaving patients to navigate years of pain, infertility and missed diagnoses. But the field is evolving. With targeted ultrasound, MRI and a shift away from diagnostic laparoscopy as the first step, clinicians now have more effective tools to identify disease earlier and guide treatment based on symptoms, not just surgical findings.This episode explores how endometriosis presents, why it's so frequently missed, and what clinicians can do to improve outcomes through earlier recognition, appropriate imaging and thoughtful referral.This episode is designed for physicians, advanced practice providers and clinicians seeking a practical understanding of endometriosis diagnosis, treatment pathways and multidisciplinary care.What We Cover• Why endometriosis is frequently underdiagnosed or misdiagnosed• The shift from surgical diagnosis to imaging-first approaches• How advanced ultrasound and MRI improve detection• Common symptoms, including pelvic pain, GI and urinary involvement• When to treat—and when not to intervene• Medical vs. surgical management strategies• Fertility considerations and treatment planning• The role of minimally invasive and robotic-assisted surgery• Multidisciplinary care, including pain management and specialty referral• How to identify patients who need earlier referralKey Topics for Clinicians• Endometriosis• Chronic pelvic pain• Minimally invasive gynecologic surgery (MIGS)• Diagnostic imaging in gynecology• Transvaginal ultrasound (sliding sign)• Pelvic MRI• Fertility and reproductive health• Multidisciplinary care models• Women's health disparities• Early referral strategiesAbout Our GuestDr. Kho is a gynecologic surgeon and endometriosis specialist at Banner - University Medicine Phoenix, with extensive experience in minimally invasive gynecologic surgery and a national reputation for advancing endometriosis diagnosis and care. She previously led programs at both Mayo Clinic and Cleveland Clinic and has published more than 90 peer-reviewed papers focused on improving outcomes for patients with endometriosis. Her work has helped shift the field toward imaging-based diagnosis and multidisciplinary treatment models.She sees patients at:Banner - University Medicine Women's Institute1441 North 12th Street, Floor 3, Phoenix, AZ 85006Phone: 602-521-5700Fax: 602-521-5701How to Refer a PatientBanner Health providers: Use Cerner's Ambulatory Referral Management (ARM) tool.Community providers: Fax referrals to 602-521-5701 or call 602-521-5700 to schedule a patient for evaluation.DisclaimerThis podcast is intended for educational purposes only and is designed for a clinical audience. Any patient scenarios discussed are modified and de-identified to protect privacy. No protected health information (PHI) is disclosed. The information presented should not replace independent medical judgment or individualized patient care decisions.Subscribe to Beyond the Rounds for physician-focused conversations on clinical innovation, specialty collaboration and evolving standards of care.

In this episode, Edward J. Dohring, M.D., of the Spine Institute of Arizona, discusses the value of multidisciplinary collaboration, emerging innovations in spine care, and the evolving role of AI and minimally invasive approaches. He also shares insights on improving patient outcomes, balancing cost and quality, and shaping the next generation of spine leaders.

In this episode, Edward J. Dohring, M.D., of the Spine Institute of Arizona, discusses the value of multidisciplinary collaboration, emerging innovations in spine care, and the evolving role of AI and minimally invasive approaches. He also shares insights on improving patient outcomes, balancing cost and quality, and shaping the next generation of spine leaders.

Experts discuss the different roles of clinicians in managing metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/multidisciplinary-management-metabolic-dysfunction-2026a1000d62?ecd=bdc_podcast_libsyn_mscpedu

A child can need support and still have too much support. In this conversation, I talk with Casey Joseph, special educator and founder of Casey's Special Education Services, about what happens when families get handed a long list of recommendations and start trying to do all of it at once. Casey shares why "more" is not always the best answer for neurodivergent kids, especially when services start to crowd out rest, connection, regulation, and ordinary family life. We talk about the hidden cost of too many appointments, too many providers, and too many moving pieces, and why parents need permission to step back and ask what is truly necessary right now. We also get into the practical side of this: how to think about a child's most urgent needs first, why fit matters more than quantity, when it may make sense to pause or reduce services, and how seasons of life affect progress too. Casey offers a thoughtful framework for choosing support with more intention and less panic, so families can build something sustainable instead of piling on one more thing just because it sounds helpful. Key Takeaways More services do not automatically mean better outcomes. A child can benefit from support and still become overwhelmed by too many appointments, transitions, and expectations. Parents need permission to be intentional. It is okay to ask what is most important right now instead of trying to address every need at the same time. Burnout matters for kids too. If a child is spending all day holding it together at school, adding too many after-school supports can push them past capacity. Burnout in parents affects the whole system. When a parent is juggling too many providers, updates, schedules, and logistics, that stress often gets felt by the child. Fit matters as much as access. A therapist, tutor, or clinician may be wonderful and still not be the right person for a particular child or diagnosis. Support should match the real priority. Sometimes the first need is regulation, anxiety support, sensory support, or basic physical needs, not academics. Services can change over time. A child may need something intensely for one season, then need less, a break, or something different later. Progress is not linear. Some parts of the year are naturally harder, and families do not need to panic if growth looks slower during stressful or draining seasons. Multidisciplinary support can help when it reduces stress. Sometimes one clinic or one coordinated team makes more sense than managing many separate providers. A good question for families is not only "What could help?" but also "What is giving us a real return on the investment of time, money, and energy?" About Casey Joseph Casey Joseph is the Executive Director and Founder of Casey's Special Education Services, LLC. She is a special educator who has built a team of special education teachers providing one-on-one support, tutoring, and consultation for families across the DMV. Casey's work focuses on children who learn differently and benefit from individualized support grounded in special education expertise. Her approach is collaborative, strengths-based, and centered on helping families find support that is both meaningful and sustainable. About Your Host, Gabriele Nicolet I'm Gabriele Nicolet, toddler whisperer, speech therapist, parenting life coach, and host of Complicated Kids. Each week, I share practical, relationship-based strategies for raising kids with big feelings, big needs, and beautifully different brains. My goal is to help families move from surviving to thriving by building connection, confidence, and clarity at home. Complicated Kids Resources and Links

Sriwhana Spong, a New Zealand-born artist of Balinese heritage based in London, is presenting her first major solo exhibition in Australia at the Monash University Museum of Art in Melbourne. - Sriwhana Spong, seniman asal Selandia Baru berdarah Bali yang berbasis di London, menghadirkan pameran tunggal perdananya di Australia di Monash University Museum of Art, Melbourne.

CME credits: 0.25 Valid until: 24-04-2027 Claim your CME credit at https://reachmd.com/programs/cme/living-with-systemic-mastocytosis-bridging-clinical-decisions-and-patient-realities/54389/ This online CME activity explores the clinical complexity and real-world impact of systemic mastocytosis through both clinician insight and patient experience. Participants will examine the multisystem burden of this disease, challenges in diagnosis, and the importance of recognizing symptoms that are often underestimated. The program reviews current evidence-based and targeted treatment strategies to support personalized care across clinical settings. Faculty also goes in-depth on shared decision-making and integrating patient perspectives into management plans. Multidisciplinary approaches to monitoring treatment response, managing adverse events, and sustaining quality of life are also highlighted.=

In this episode, Dr. Steve Gard, Editor-in-Chief of the Journal of Prosthetics and Orthotics, is joined by Aarti Deshpande, MS, CPO, FAAOP, clinical manager at the University of California San Francisco Orthotic and Prosthetics Center, to discuss her 2026 Academy Annual Meeting session, “Lessons From Sustained Multidisciplinary Research Collaborations in Global Rehabilitation.” Drawing on experience across India, the UK, and the United States, Deshpande shares how different healthcare systems shaped her approach to equity and outcome-based care. She unpacks what true multidisciplinary collaboration looks like in practice—bringing together clinicians, researchers, trainees, administrators, and funders around a shared, patient-centered goal. The conversation explores how research can directly inform clinical workflows, policy, and long-term program sustainability, along with the skills that make collaboration effective, including listening, cultural humility, and intentional, two-way planning. Deshpande also addresses the real-world challenges—cultural and language differences, logistics, ethics, and infrastructure limitations—that can complicate global work. Throughout the episode, she underscores the urgency of addressing global access gaps and workforce shortages, while offering practical insight into building sustainable, locally grounded solutions and translating evidence into meaningful practice.   O&P Research Insights is produced by Association Briefings.

For patient referrals: Call 602-521-5969 or 602-839-4242What if restoring a patient's core function required more than just closing a defect? In this episode of Beyond the Rounds, we explore complex abdominal wall reconstruction—one of the most technically demanding areas in surgery—and why a multidisciplinary approach is essential for achieving optimal outcomes. Dr. Nolan Fisher sits down with plastic and reconstructive surgeon Dr. Jimmy Chim and general surgeon Dr. Priya Rajdev to discuss how collaboration, surgical innovation and thoughtful pre-operative planning are redefining what's possible for patients with complex hernias and abdominal wall defects.Far beyond a “simple hernia repair,” these cases often involve loss of domain, prior surgical complications or missing abdominal wall components that significantly impact a patient's function and quality of life. From minimally invasive techniques to advanced reconstructive procedures, today's surgical approaches are focused not just on repair, but on restoring strength, stability and independence.This episode explores how these procedures work, which patients may benefit and why optimizing health before surgery is often just as important as the operation itself.This episode is designed for physicians, advanced practice providers and clinicians seeking a practical understanding of complex hernia repair, abdominal wall reconstruction and multidisciplinary surgical care.What We Cover-Why not all hernia repairs are the same—and when cases become “complex”-The concept of loss of domain and its impact on surgical planning-Differences between minimally invasive and open reconstruction techniques-How component separation restores abdominal wall function-The role of mesh—synthetic, biologic and bio-resorbable options-When and why plastic surgery and general surgery collaborate-Prehabilitation: weight loss, diabetes control and smoking cessation-Managing recurrence and why the first repair matters most-Surgical staging vs. single-stage reconstruction-Real-world cases highlighting decision-making and techniqueKey Topics for Clinicians-Complex abdominal wall reconstruction-Ventral and incisional hernias-Loss of domain-Component separation techniques-Minimally invasive hernia repair-Surgical mesh selection-Preoperative optimization (prehab)-Multidisciplinary surgical care-Plastic and reconstructive surgery collaboration-Hernia recurrence preventionAbout Our Guests-Dr. Jimmy Chim is a plastic and reconstructive surgeon specializing in complex abdominal wall reconstruction and advanced soft tissue reconstruction. His work focuses on restoring both form and function for patients with significant surgical defects, trauma or prior complications.-Dr. Priya Rajdev is a general surgeon specializing in minimally invasive foregut and complex abdominal wall surgery. She brings expertise in laparoscopic and robotic techniques to treat hernias and abdominal wall defects through smaller incisions while maintaining strong clinical outcomes.How to Refer a PatientBanner Health providers: Use Cerner's Ambulatory Referral Management (ARM) tool.Community providers: Call 602-521-5969 or 602-839-4242 to schedule a patient for evaluation.DisclaimerThis podcast is intended for educational purposes only and is designed for a clinical audience. Any patient scenarios discussed are modified and de-identified to protect privacy. No protected health information (PHI) is disclosed. The information presented should not replace independent medical judgment or individualized patient care decisions.Subscribe to Beyond the Rounds for physician-focused conversations on clinical innovation, specialty collaboration and evolving standards of care.

Hello everyone. Welcome to the latest episode of The Matchbox Podcast powered by Ignition Coach Co. I'm your host, Adam Saban, and on this week's episode we're talking about whether or not adding weekly volume at Z3 is beneficial and should you be using those handy side bib pockets if aero is your number one concern?   As always, if you like what you hear, share this with your friends and leave us a five star review and if you have any questions for the show drop us an email at matchboxpod@gmail.com or head over to ignitioncoachco.com and fill out The Matchbox Podcast listener question form.    Alight let's get into it!   For more social media content, follow along @ignitioncoachco @adamsaban6 @dizzle_dillman @dylanjawnson @kait.maddox     https://patreon.com/MatchboxPodcast?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink   https://www.youtube.com/c/DylanJohnsonCycling https://www.ignitioncoachco.com  https://www.youtube.com/@DrewDillmanChannel   Intro/ Outro music by AlexGrohl - song "King Around Here" - https://pixabay.com/music/id-15045/    Summary   In this episode, hosts tackle a listener's complex training schedule that involves preparing for both trail running and ultra bikepacking, while also managing late-night training routines as a busy parent. The discussion offers actionable insights on balancing multi-discipline training, periodization, strength maintenance, and optimizing sleep and recovery.Main Topics Covered: Strategies for training simultaneously for trail running and bikepacking events The importance of periodization and training ratios (running vs cycling) Incorporating strength and mobility work effectively Managing late-night training sessions and routines as a parent The nuanced use of critical power versus FTP for training zones Tools and platforms: WKO5 vs Vekta for training analysis In this episode: We analyze how to periodize training around a 30K trail race and an 800-mile bikepacking race spaced out over months Discussion on prioritization: focusing on the main event while maintaining fitness for the secondary event The role of strength training, plyometrics, and mobility in endurance performance Tips for late-night workouts, sleep considerations, and routine creation as a parent Insights into training tools, zones, and metrics, including Vecta's adaptive zones and the W prime metric Tips for athletes balancing intense training with life's obligations Timestamps: 00:00 - Introduction to multi-discipline endurance training challenges 01:11 - Can you train effectively for both trail running and bikepacking simultaneously? 02:25 - Importance of training ratios: near 50-50 split or tailored approach 03:13 - Prioritizing running for injury prevention and muscular efficiency 04:08 - Cycling complements running; form and nutrition focus for trail run 05:38 - Periodization strategies: focusing on the main event and maintaining secondary fitness 06:48 - Incorporating strength training and its timing relative to the season 08:11 - Reducing gym volume as race approaches, maintaining strength efficiently 12:58 - Role of mobility and plyometrics in injury prevention and running performance 14:39 - Challenges of fitting training into busy schedules; structuring routine 17:49 - Impact of late-night training routines on sleep and recovery 20:50 - How to adapt training around parenting schedules; morning vs night workouts 25:33 - Coaching insights: Using Vecta and critical power zones 29:44 - Comparing training platforms: WKO5 vs Vecta 32:40 - Final tips: balance, discipline, and leveraging tools for progress  

In this episode, surgical oncologist Dr. Seth Concors of Emory's Winship Cancer Institute discusses the role of the surgical oncologist within the multidisciplinary care team for neuroendocrine cancer. We explore what surgical oncologists do, why NET-specific experience matters, how surgical decisions are made, and what patients can expect during a surgical consultation. The conversation highlights coordination across care teams, common patient concerns, and the importance of informed decision-making and second opinions, offering practical guidance for patients and caregivers navigating surgical care in neuroendocrine cancer.TOP TEN QUESTIONS Understanding the Surgeon's Role1. What is a surgical oncologist, and what kind of training does that involve? How is a surgical oncologist similar to—or different from—other types of surgeons? Patients may hear the term “HPB surgeon.” What does that mean, and how can a patient tell if their surgeon is an HPB surgeon? 2. When a patient is looking for a surgeon, how can they find someone who is the “right fit” for them? How can patients know whether a surgeon has experience with the specific operation they may need—such as a Whipple procedure, liver surgery, or lung surgery? How important is it for a surgeon to be familiar with neuroendocrine tumors specifically?3. What should patients expect at their first appointment with a surgical oncologist? What key information are you usually trying to communicate during that first visit? What questions do you encourage patients and caregivers to ask their surgeon?4. How often should patients expect to see their surgical oncologist, and at what points in their care?Surgical Decision-Making5. How do you determine whether someone is a surgical candidate?  What is the typical goal of surgery for neuroendocrine tumors?6. If someone is not a surgical candidate initially, does that mean surgery is off the table forever? Are there treatments that can help make surgery possible in the future? How many NET surgeries can someone safely have over their lifetime? Can major surgeries—such as extensive liver resections—affect eligibility for future treatment options?Multidisciplinary and Coordinated Care7. How do surgical oncologists work within a multidisciplinary care team for NET patients? How do you collaborate with providers at different institutions, such as a local oncologist working with a NET specialty center?8. What is your perspective on second opinions, specifically for neuroendocrine cancer?9. Many patients worry about carcinoid crisis during surgery. How do you address and manage those concerns?Preparing for Surgery10. Patients often ask how they can best prepare—physically and emotionally—for surgery. What guidance do you typically offer?BONUS: What research is currently being done involving neuroendocrine surgery?ABOUT THE SPEAKERSeth Concors, MD, is an academic surgical oncologist at Emory University and the Winship Cancer Institute, where he serves as Associate Program Director for both the General Surgery Residency and the Complex General Surgical Oncology Fellowship, and Director of the Surgical Oncology Research Fellowship. He leads Emory's Peritoneal Surface Malignancy and Neuroendocrine Tumor surgical programs, with clinical and research interests focused on gastrointestinal neuroendocrine tumors, cytoreductive surgery/HIPEC, and survivorship outcomes. Dr. Concors is actively involved in national surgical societies, including SSO, SSAT, NANETS, ACS, and ECOG-ACRIN, and his work emphasizes multidisciplinary collaboration, prospective outcomes research, and surgical education. He is committed to advancing patient-centered cancer care while mentoring the next generatioFor more information, visit NCF.net. 

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Featuring slide presentations and related discussion from Dr Nikhil I Khushalani, Dr Soo J Park, Dr Vishal Anil Patel and Dr Evan Wuthrick, including the following topics: Introduction (0:00) Current Management of Localized, Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) (9:55) Case: A man in his early 70s with cSCC who previously underwent surgery and adjuvant therapy (32:39) Case: A man in his early 60s with cSCC who receives cemiplimab (54:45) Incorporation of Radiation Therapy into the Multidisciplinary Management of cSCC and Basal Cell Carcinoma (BCC) (1:04:24) Case: A man in his early 70s with cSCC who receives radiation therapy after a surgeon expresses concern about the risks of surgery (1:22:15) Case: A man in his late 80s with cSCC who is not a candidate for surgery (1:24:09) Evidence-Based Treatment Strategies for Patients with BCC (1:26:00) Case: A man in his mid sixties with BCC who receives sonidegib (1:36:49) Case: A man in his late 70s with BCC who receives vismodegib (1:38:32) Dermatologic Care for Patients with cSCC and BCC (1:45:09) CME information and select publications

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHF865. CME/AAPA/IPCE credit will be available until March 18, 2027.Paving the Path Forward for Desmoid Tumors: Multidisciplinary Tactics to Effectively Implement Gamma Secretase Inhibitors in Clinical Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Society of Surgical Oncology. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.

This week, Wes and Todd reconnect with their friend, multidisciplinary artist, Joey Kerlin. Joey discusses beauty, ceramics, the catalyst to getting back into teaching, critical thinking, teaching philosophy, writing & reading, art weirdos, the book “Art & Fear”, imposter syndrome, literacy, Catholic churches, transubstantiation, beholding, Marina Abramoić, how teaching informs his art practice, arts & education, bean pots, boredom, vulnerability & relationships, art & loneliness, titles, the “OFF-PRINSTE” exhibition, borders, birds & women, chairs, divergent vs. convergent thinking, the “Black Ink” fundraiser, this year's “Hearsay” exhibition and the piece he's submitting, and the challenges & virtues of being an Artist.Join us for a thought provoking conversation with Joey Kerlin!Follow Joey Kerlin on social media:Instagram - www.instagram.com/radiusstudios/ - @radiusstudios See Joey's work in person at these exhibitions; OFF-PRINSTE – March 3rd – April 26thThe People's Building9995 E. Colfax AvenueAurora, CO 80010Secondary Reception: April 3rd, 5pm - 8pm Black Ink – a fundraiser for Mo' Print – Month of Printmaking Colorado@moprintcoloradoSaturday, April 4th, 6pm – 11pmHigh Dive Denver7 S. BroadwayDenver, CO 80223All prints - $10  Hear/Say – Groundbreaking Art Exhibition Exploring the Effects of High-Concentration Cannabis May 29th - May31st, 2026Center for Creativity200 Matthews StreetFort Collins, CO 80524Opening reception – May 29th, 6pm – 8pm  June 5th – June 26th, 2026Cottonwood Center for the Arts427 E. Colorado AvenueColorado Springs, CO 80903Opening reception – June 5th, 6pm – 8pmSend us Fan MailFollow us on Instagram:@tenetpodcast - www.instagram.com/tenetpodcast/@wesbrn - www.instagram.com/wesbrn/@toddpiersonphotography - www.instagram.com/toddpiersonphotography/ Follow us on Facebook:www.facebook.com/TenetPodcast/Email us at todd@toddpierson.com If you enjoyed this episode or any of our previous episodes, please consider taking  a moment and leaving us a review on your favorite podcast platform.Thanks for listening! 

A “wardrobe malfunction” during the 2004 Superbowl halftime show caused a huge furore and changed the course of Janet Jackson's career for decades, while her fellow performer, Justin “Trousersnake” Timberlake thrived. Multidisciplinary artist Paula Varjack's play, Nine Sixteenths, examines the impact of the infamous “Nipplegate” incident. Jen chats to Paula about the play, the forces of racism, sexism and ageism that conspired to derail Jackson, and the hypocrisy that underlines pop culture. As ever, there's more available for our £5 and above patreons, and you can become one of those by visiting patreon.com/standardissue. Learn more about your ad choices. Visit megaphone.fm/adchoices

This inaugural episode of the CardioNerds Pulmonary Embolism (PE) Series explores the evolution of acute PE care. Dr. Ibrahim Zahid, Dr. Dinu Balanescu, and Dr. Billy Joe Mullinax join guest expert Dr. Kenneth Rosenfield to discuss the shifting landscape of PE management. Pulmonary embolism (PE) remains a leading cause of cardiovascular mortality and a frequent diagnostic challenge, often masquerading as myocardial infarction or a benign illness. Over the past decade, PE care has evolved from anticoagulation-only strategies to nuanced, risk-stratified, multidisciplinary management. Modern approaches integrate hemodynamics, biomarkers, and advanced imaging to guide therapy, including catheter-directed interventions and large-bore thrombectomy. The Pulmonary Embolism Response Team (PERT) model addresses historical gaps by coordinating rapid, multispecialty decision-making and standardizing care pathways. The PERT Consortium further advances PE care through education, research, and the world's largest PE registry, while fostering leadership and research opportunities for trainees. Despite advances, long-term outcomes and post-PE syndromes remain important areas for future investigation. Audio editing by CardioNerds Academy intern, student doctor, Pace Wetstein. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Pulmonary Embolism PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls PE is a “master masquerader”—maintain suspicion for atypical presentations like myocardial infarction, heart failure, flu, or anxiety. Multidisciplinary management mediated through pulmonary embolism response teams improves outcomes and standardizes care. Risk stratification integrates hemodynamics, biomarkers, and imaging. Advanced therapies have expanded beyond anticoagulation. Long‑term follow‑up and post‑PE syndrome need more research. Notes Notes: Notes drafted by Dr. Ibrahim Zahid. 1. How has the clinical approach to PE changed over the past decade? PE is the third leading cause of cardiovascular death and historically under‑recognized. Symptoms mimic MI, HF, asthma, syncope, and more.PE is a silent killer, and it should be recognized more as a cause of spontaneous cardiac arrest. Where life threatening disease like stroke which is owned by neurological specialists and MI is primarily managed by cardiac specialists, PE is an entity without a professional home. The PERT Consortium brings the specialties together for PE care. 2. Ten years ago, a 58-year-old patient with a large bilateral PE, RV dilation, and positive biomarkers might have been managed with anticoagulation and close observation alone. Today, with evolving—but still uneven—data on advanced therapies, PE care feels far more nuanced and highly dependent on where you practice. What are the major gaps in traditional PE management that clinicians should recognize, and what care pathways should they be aware of across different hospital systems? Care has shifted from anticoagulation‑only to multidisciplinary approaches like catheter directed thrombectomy. Risk‑based pathways and the use of CT angiogram has improved early recognition. Risk stratification tools must be used as tools for early recognition of intermediate risk PE. Untreated PE leads to chronic complications like chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension, which requires long term clinic follow up. 3. What is the role of risk stratification tools such as PeSI, sPeSI scores, cardiac biomarkers, and imaging findings in PE, and how do they guide treatment decisions in real world practice? Integrate vitals (blood pressure and heart rate), biomarkers (troponin, pro-BNP), RV/LV ratio assessment, acid‑base status, and scores. Tools include PESI, sPESI, BOVA, HESTIA, FAST, Geneva, NEWS, shock index. Vitals, lactate, acid-base status, and tools like NEWS or shock index track clinical evolution. PESI/sPESI estimate 30-day mortality and help identify low-risk patients who may be candidates for early discharge or outpatient therapy. Clinical judgment matters—scores don't fully capture clot burden, trajectory, or bleeding risk. 4. How was the pulmonary embolism response team created, and since its creation, what evidence or outcome data became available to support the PERT model? Originated after a sentinel case at MGH: A young, pregnant woman in her 30s, who collapsed at home, underwent thrombectomy, and had to be on ECMO for a few days. The case brought cardiology, cardiac surgeons and critical care physicians together for planning and improvement in her health, which was rewarding. Thereby, it was decided to bring specialties involved in PE care together to create a response team. The name of the team, Pulmonary Embolism Response Team (PERT), was coined by Richard Channick in the first meeting. Posters were set up all over the hospital to call a centralized line when an acute PE is recognized A meeting was held to present the concept of putting together a consortium, with development of action items and a PERT database. Enabled rapid multidisciplinary input using early teleconferencing tools. 5. Given concerns about having too many ‘cooks in the kitchen' during the initial PE call—especially with rotating teams—how can institutions reconcile workflow complexity with standardized pathways in a way that meaningfully supports and justifies the added burden on frontline clinicians? Every hospital's PERT is different, catering to their needs and workflow At least two disciplines are needed to make a PERTData is currently being collected to guide further on how the workflow can be standardized Most importantly, the team brings in resources that were not available prior to PERT formation. 6. What are the main goals of the PERT consortium, and how does it support clinicians and institutions involved? To improve care and improve outcomes for patients with PE Expand education, refine algorithms, standardize care with Centers of Excellence. Maintain the largest PE registry for research and outcomes improvement. 7. Beyond global networking, shared learning from successful systems, and the pathway toward Center of Excellence designation, what additional benefits can clinicians and health systems gain by participating in the PERT Consortium? The ability to learn from other systems, the ability to share experiences. Allow people to develop their professional careers like leadership experience, becoming a member of the trainee council Initiate projects and receive funding for your ideas 8. For trainees interested in pulmonary embolism care, how can a trainee be a champion at their institution? Does PERT provide assistance and how can they really contribute meaningfully even before becoming a fellow/attending? Medical students and residents interested in PE should reach out to the consortium and the consortium will hook you up with the correct mentors who can nurture you along. Listen to the podcasts. Participate with your local PERT team PERT wants involvement of people who are social media savvy to help spread the word on PE. Top three take-away points from this episode Acute PE care has advanced and multiple treatment modalities for acute PE including catheter directed therapy, large bore thrombectomy, are becoming standard of care. Multidisciplinary models like PERT improve coordination and outcomes. Trainees play a vital role in advancing PE care through involvement, research, and education References Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405. PMID: 31504429. https://pubmed.ncbi.nlm.nih.gov/31504429/ Rosovsky R, Zhao K, Sista A, Rivera-Lebron B, Kabrhel C. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost. 2019 Jun 9;3(3):315-330. doi: 10.1002/rth2.12216. PMID: 31294318; PMCID: PMC6611377. https://pmc.ncbi.nlm.nih.gov/articles/PMC6611377/ Rosenfield K, Bowers TR, Barnett CF, Davis GA, Giri J, Horowitz JM, Huisman MV, Hunt BJ, Keeling B, Kline JA, Klok FA, Konstantinides SV, Lanno MT, Lookstein R, Moriarty JM, Ní Áinle F, Reed JL, Rosovsky RP, Royce SM, Secemsky EA, Sharp ASP, Sista AK, Smith RE, Wells P, Yang J, Whatley EM; Pulmonary Embolism Research Collaborative (PERC) Attendees. Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative. Circulation. 2024 Oct;150(14):1140-1150. doi: 10.1161/CIRCULATIONAHA.124.067482. Epub 2024 Sep 12. PMID: 39263752; PMCID: PMC11698503. https://pubmed.ncbi.nlm.nih.gov/39263752/ Sharifi M, Awdisho A, Schroeder B, Jiménez J, Iyer P, Bay C. Retrospective comparison of ultrasound facilitated catheter-directed thrombolysis and systemically administered half-dose thrombolysis in treatment of pulmonary embolism. Vasc Med. 2019 Apr;24(2):103-109. doi: 10.1177/1358863X18824159. Epub 2019 Mar 5. PMID: 30834822. https://pubmed.ncbi.nlm.nih.gov/30834822/ Pandya V, Chandra AA, Scotti A, Assafin M, Schenone AL, Latib A, Slipczuk L, Khaliq A. Evolution of Pulmonary Embolism Response Teams in the United States: A Review of the Literature. J Clin Med. 2024 Jul 8;13(13):3984. doi: 10.3390/jcm13133984. PMID: 38999548; PMCID: PMC11242386. https://pubmed.ncbi.nlm.nih.gov/38999548/ Rivera-Lebron B., McDaniel M., Ahrar K., Alrifai A., Dudzinski D.M., Fanola C., Blais D., Janicke D., Melamed R., Mohrien K., et al. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clin. Appl. Thromb. Hemost. 2019;25:1076029619853037. doi: 10.1177/1076029619853037.https://pubmed.ncbi.nlm.nih.gov/31185730/

Slate writer Scaachi Koul unpacks her latest book of essays Sucker Punch, in which she delves into her unexpected birth, the dissolution of her marriage, and how her friends have come to know her as "the divorce doula." Multidisciplinary artist Emma Ruth Rundle explains how she crafted her debut poetry collection The Bella Vista – which touches on love lost, addiction, and discovering oneself – while traveling on tour, then performs “Blooms of Oblivion” from her album Engine of Hell.